Delivery Order SPE2DR25D1053-SPE2DR26FV421
Award Date 1/12/26
Potential Completion Date 1/13/26
Potential Value $10K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $36,484.03 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injections, with an ultimate completion date of January 7, 2026. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,359.38 to AmerisourceBergen Drug Corp for the supply of Zepbound 15 mg/0.5 mL pens on November 26, 2025, with completion expected by November 28, 2025. This is a firm fixed price delivery order with no set-aside designation, awarded competitively under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical product will be delivered to AmerisourceBergen's corporate...
- The Defense Logistics Agency (DLA) awarded a $16,914.66 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pens on July 14, 2025, with completion targeted for July 15, 2025. This non-set-aside contract represents a single delivery order issued under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's Conshohocken, Pennsylvania location, which...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,163.90 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pens on September 26, 2025, with completion targeted for September 29, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be delivered to AmerisourceBergen's facility in...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 mL pens valued at $10,335.92 on November 5, 2025, with completion scheduled for November 6, 2025. This firm fixed-price delivery order represents a non-competitive award under the company's existing indefinite delivery contract vehicle with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is one of the nation's largest pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a $34.5K delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pens on January 12, 2026, with completion scheduled for January 13, 2026. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through full and open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, with its parent company Cencora, Inc....
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $16,157.68 on December 18, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injections. This non-competitive, firm fixed-price delivery order is set to be completed by December 19, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a $17.1K delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pens with a completion date of September 22, 2025. This is a firm fixed-price, non-set-aside delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The contract specifies performance at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $26,192.52 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pen injectors on December 29, 2025, with an ultimate completion date of December 30, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with DLA's Medical Supply Chain. The contract contains no set-aside designation and will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $15,743.09 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pens on January 5, 2026, with completion scheduled for January 6, 2026. This competitively awarded, firm fixed-price delivery order represents a pharmaceutical supply fulfillment under the company's broader pharmaceutical support framework. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor within the Defense...